CCM
PAND

Chicago Capital Management’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Chicago Capital Management’s Portfolio PAND Stock Details PAND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-65,636
Closed -$3.94M – 54
2021
Q1 		$3.94M Buy
+65,636
New +$2.38M 1.83% 21

Chicago Capital Management's PAND Position: Q2 2021 in Review

Chicago Capital Management sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 65,636 shares — an estimated $3.94M sold.

Chicago Capital Management first reported a position in PAND in Q1 2021 and held it in 1 quarter. The position peaked at $3.94M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

  • Chicago Capital Management reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Chicago Capital Management sold 65,636 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $3.94M.
  • Chicago Capital Management first reported a position in Pandion Therapeutics Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Chicago Capital Management's Pandion Therapeutics Inc. Common Stock position peaked at $3.94M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Chicago Capital Management's 13F filing for Q2 2021, filed 11 Aug 2021.